DE60026347D1 - Anwendung von nicht menschliches SHIP2 'Knock-out' Säugtiere - Google Patents

Anwendung von nicht menschliches SHIP2 'Knock-out' Säugtiere

Info

Publication number
DE60026347D1
DE60026347D1 DE60026347T DE60026347T DE60026347D1 DE 60026347 D1 DE60026347 D1 DE 60026347D1 DE 60026347 T DE60026347 T DE 60026347T DE 60026347 T DE60026347 T DE 60026347T DE 60026347 D1 DE60026347 D1 DE 60026347D1
Authority
DE
Germany
Prior art keywords
knock
mammals
ship2
inhibitor
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60026347T
Other languages
English (en)
Other versions
DE60026347T2 (de
Inventor
Christophe Erneux
Stephane Schurmans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ogeda SA
Original Assignee
Euroscreen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen SA filed Critical Euroscreen SA
Application granted granted Critical
Publication of DE60026347D1 publication Critical patent/DE60026347D1/de
Publication of DE60026347T2 publication Critical patent/DE60026347T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Liquid Crystal (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60026347T 1999-11-03 2000-10-31 Anwendung von nicht menschliches SHIP2 'Knock-out' Säugtiere Expired - Lifetime DE60026347T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870229 1999-11-03
EP99870229A EP1097713A1 (de) 1999-11-03 1999-11-03 Inhibitoren von Inositol-Phosphatase ship-2 Moleküle
PCT/BE2000/000132 WO2001032186A2 (en) 1999-11-03 2000-10-31 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule

Publications (2)

Publication Number Publication Date
DE60026347D1 true DE60026347D1 (de) 2006-04-27
DE60026347T2 DE60026347T2 (de) 2006-12-14

Family

ID=8243920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60026347T Expired - Lifetime DE60026347T2 (de) 1999-11-03 2000-10-31 Anwendung von nicht menschliches SHIP2 'Knock-out' Säugtiere

Country Status (9)

Country Link
US (4) US6703215B2 (de)
EP (2) EP1097713A1 (de)
JP (1) JP2003515532A (de)
AT (1) ATE318511T1 (de)
CA (1) CA2388180C (de)
DE (1) DE60026347T2 (de)
DK (1) DK1244433T3 (de)
ES (1) ES2259293T3 (de)
WO (1) WO2001032186A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097713A1 (de) * 1999-11-03 2001-05-09 Euroscreen S.A. Inhibitoren von Inositol-Phosphatase ship-2 Moleküle
US20020165192A1 (en) * 2000-09-19 2002-11-07 Kerr William G. Control of NK cell function and survival by modulation of ship activity
US7691821B2 (en) * 2001-09-19 2010-04-06 University Of South Florida Inhibition of SHIP to enhance stem cell harvest and transplantation
AU2001292753A1 (en) * 2000-09-19 2002-04-02 University Of South Florida Control of nk cell function and survival by modulation of ship activity
US20070224124A1 (en) * 2002-09-30 2007-09-27 University Of South Florida Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
US7763592B1 (en) 2003-11-20 2010-07-27 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
US7807646B1 (en) * 2003-11-20 2010-10-05 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
EP1987837A1 (de) * 2007-05-02 2008-11-05 Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus Pharmazeutische Zusammensetzung zur Erhöhung der Insulinsekretion aus Pankreas-ß-Zellen
WO2012169571A1 (ja) * 2011-06-09 2012-12-13 国立大学法人 富山大学 新規なｎ－（ピリジン－２－イル）アルカンアミド誘導体およびそれらを有効成分とするｓｈｉｐ２阻害剤
US20170336425A1 (en) * 2016-05-18 2017-11-23 The Cleveland Clinic Foundation Pip2 as a marker for hdl function and cardiovascular disease risk

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023248A (en) * 1984-10-23 1991-06-11 Perstorp Ab Method of treating diabetes with inositol triphosphate
JP2750239B2 (ja) * 1991-08-14 1998-05-13 三共株式会社 アデノホスチンａまたはｂならびにその製法
US6218162B1 (en) * 1995-09-27 2001-04-17 Gerald Krystal SH2-containing inositol-phosphatase
GB9525702D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Process for activating a kinase
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
CN1478783A (zh) * 1996-09-20 2004-03-03 加利福尼亚大学董事会 肌醇多磷酸酯衍生物及其使用方法
US6025198A (en) * 1999-06-25 2000-02-15 Isis Pharmaceuticals Inc. Antisense modulation of Ship-2 expression
EP1097713A1 (de) * 1999-11-03 2001-05-09 Euroscreen S.A. Inhibitoren von Inositol-Phosphatase ship-2 Moleküle

Also Published As

Publication number Publication date
US20040203087A1 (en) 2004-10-14
EP1097713A1 (de) 2001-05-09
US6703215B2 (en) 2004-03-09
WO2001032186A3 (en) 2002-07-25
DE60026347T2 (de) 2006-12-14
US6936452B2 (en) 2005-08-30
ATE318511T1 (de) 2006-03-15
US20040209342A1 (en) 2004-10-21
US20020106713A1 (en) 2002-08-08
US20050183146A1 (en) 2005-08-18
WO2001032186A2 (en) 2001-05-10
JP2003515532A (ja) 2003-05-07
US7094546B2 (en) 2006-08-22
ES2259293T3 (es) 2006-10-01
DK1244433T3 (da) 2006-07-10
CA2388180A1 (en) 2001-05-10
EP1244433A2 (de) 2002-10-02
EP1244433B1 (de) 2006-03-01
CA2388180C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
DE69620241T2 (de) Gonadotropin releasing hormon- antagonisten
BR9708632A (pt) Composto calcilìticos
ATE218859T1 (de) Liganden des neuropeptids y
BR0113666A (pt) Inibidores da protease peptidomimética
CO5011115A1 (es) Compuestos y metodos quimioquina
DE60026347D1 (de) Anwendung von nicht menschliches SHIP2 'Knock-out' Säugtiere
BR9305722A (pt) Composiçoes detergentes incolores com estabilidade aperfeiçoada
DE69408666D1 (de) Risperidon pamoate
NO954320D0 (no) Lyosfærer omfattende gonadotropin
KR880009910A (ko) 리폭시게네이즈 억제 화합물
DE69912279D1 (de) 5-ht1f agonisten
TR199801582T2 (xx) Bakteri �ld�r�c� ve mantar �ld�r�c� peptit.
SE9300012D0 (sv) New peptides
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
BR9813208A (pt) Antagonista receptor de vitronectina
SV2002000244A (es) Metodos y compuestos para inhibir mrp1 ref.x-13353
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
RS50002B (sr) Eletriptan hidrobromid monohidrat
BR9915879A (pt) Antagonista de receptor de vitronectina
AR020106A1 (es) Variantes estabilizadas del inhibidor de la subtilisina de streptomyces, gen mutante que la codifica y composicion que comprende dicha variante
DE50000033D1 (de) Haarwaschmittel
NO308829B1 (no) Anvendelse av forbindelsen finasterid for fremstilling av et preparat for behandling av kronisk prostatitt hos menn
FI991441A (fi) Peptidiyhdisteitä erityisesti LHRH-antagonisteja
ECSP034422A (es) Inhibidores de la trombina que contiene un grupo de aminoisoquinolina
WO2000023059A3 (en) Use of anticonvulsant derivatives for treating alcohol dependency

Legal Events

Date Code Title Description
8364 No opposition during term of opposition